Primary Site >> Colorectal Cancer
Gene >> CHPT1
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
Ref: Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives. PMID: 7766631 |
Ref: Clinical trials of irinotecan hydrochloride (CPT, campto injection, topotecin injection) in Japan. PMID: 8993523 |
Ref: Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties. PMID: 10383158 |
Ref: A novel B-ring modified homocamptothecin, 12-Cl-hCPT, showing antiproliferative and topoisomerase I inhibitory activities superior to SN-38. PMID: 11762642 |
Ref: Ceramide involvement in homocamptothecin- and camptothecin-induced cytotoxicity and apoptosis in colon HT29 cells. PMID: 11894136 |
Ref: Cytotoxic effect of different camptothecin formulations on human colon carcinoma in vitro. PMID: 15457131 |
Ref: [Three cases with liver metastasis from gastric or colon cancer successfully treated with S-1 combined with CPT- 11]. PMID: 18799916 |
Ref: Moxifloxacin increases anti-tumor and anti-angiogenic activity of irinotecan in human xenograft tumors. PMID: 20025849 |
Ref: RECQL5 is an important determinant for camptothecin tolerance in human colorectal cancer cells. PMID: 21210765 Ref: Surface-modified silica nanoparticles for tumor-targeted delivery of camptothecin and its biological evaluation. PMID: 21756949 |